Viewing Study NCT05738057

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:07 PM
Ignite Modification Date: 2026-06-03 @ 11:49 PM
Study NCT ID: NCT05738057
Status: RECRUITING
Last Update Posted: 2023-11-29
First Post: 2023-02-14
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Combined Therapy Using D-TACE, Gemcitabine and Cisplatin, and PD1 Antibody in Advanced and Unresectable Intrahepatic Cholangiocarcinoma
Sponsor: Hua Li
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Unresectable Intrahepatic Cholangiocarcinoma View
Keywords: